CAP Accreditation, CLIA Certifications and State Licenses
The HudsonAlpha Clinical Services Lab (CSL) offers personalized genomic testing for the identification of rare and undiagnosed disease. The sequencing and interpretation pipeline is accredited by the College of American Pathologists (CAP) and certified through Clinical Laboratory Improvement Amendments (CLIA). Whole genome sequencing at the HudsonAlpha Clinical Services Laboratory is performed on Illumina HiSeq X Ten machines at the HudsonAlpha Institute for Biotechnology. The HudsonAlpha Clinical Services Lab’s unique informatics platform provides tertiary analysis, resulting in a fully-interpreted genomic result delivered to ordering physicians. Clinical sequencing without full interpretation and analysis is also available.
Consistent with Laboratory Developed Tests, CSL’s personalized genomic testing has not been cleared or approved by the U. S. Food and Drug Administration.
The HudsonAlpha Clinical Services Lab does not accept orders from Florida, New York, and Rhode Island.